T2 Biosystems, Inc. (TTOO) financial statements (2021 and earlier)

Company profile

Business Address 101 HARTWELL AVENUE
LEXINGTON, MA 02421
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments115142737474
Cash and cash equivalents115142737474
Restricted cash and investments     0
Receivables320000
Inventory, net of allowances, customer advances and progress billings431110
Inventory431110
Other undisclosed current assets111111
Total current assets:195744757675
Noncurrent Assets
Operating lease, right-of-use asset3
Property, plant and equipment671014113
Restricted cash and investments000000
Other noncurrent assets000000
Deferred tax assets, net    0
Total noncurrent assets:1081114114
TOTAL ASSETS:286455908779
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1577656
Accounts payable411111
Accrued liabilities1166544
Employee-related liabilities     2
Deferred revenue0
Debt434241140
Deferred rent credit 0
Derivative instruments and hedges, liabilities222   
Deferred revenue and credits2320
Deferred tax liabilities    0
Contract with customer, liability1
Other undisclosed current liabilities     (2)
Total current liabilities:61525210125
Noncurrent Liabilities
Long-term debt and lease obligation2 1402621
Long-term debt, excluding current maturities  1402621
Operating lease, liability2
Liabilities, other than long-term debt011120
Deferred revenue and credits1110
Deferred revenue0
Contract with customer, liability0
Deferred rent credit 0
Other liabilities   000
Total noncurrent liabilities:212402821
Total liabilities:625354504026
Stockholders' equity
Stockholders' equity attributable to parent(34)111394753
Common stock000000
Additional paid in capital342329267243196157
Accumulated deficit(376)(317)(266)(204)(149)(104)
Total stockholders' equity:(34)111394753
TOTAL LIABILITIES AND EQUITY:286455908779

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues8115430
Revenue, net5430
Cost of revenue(17)(15)(12)(7)(2) 
Cost of goods and services sold (1)(12)(7)(2) 
Gross profit:(8)(5)(7)(3)10
Operating expenses(44)(40)(46)(48)(44)(31)
Operating loss:(52)(45)(54)(51)(43)(31)
Nonoperating income
(Other Nonoperating income)
010000
Interest and debt expense(0)  (0)(2)(1)
Loss before gain (loss) on sale of properties:(52)(44)(54)(51)(45)(31)
Other undisclosed net loss(7)(7)    
Net loss:(59)(51)(54)(51)(45)(31)
Other undisclosed net income (loss) attributable to parent  (9)(4)00
Net loss attributable to parent:(59)(51)(62)(55)(45)(31)
Preferred stock dividends and other adjustments     (5)
Net loss available to common stockholders, diluted:(59)(51)(62)(55)(45)(36)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(59)(51)(54)(51)(45)(31)
Comprehensive loss:(59)(51)(54)(51)(45)(31)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   (4) 0
Comprehensive loss, net of tax, attributable to parent:(59)(51)(54)(55)(45)(31)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: